Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$3.81 - $6.76 $233,084 - $413,556
-61,177 Reduced 33.29%
122,580 $507,000
Q4 2022

Feb 13, 2023

BUY
$4.26 - $6.84 $782,804 - $1.26 Million
183,757 New
183,757 $856,000
Q2 2022

Aug 11, 2022

BUY
$8.35 - $21.89 $113,317 - $297,069
13,571 New
13,571 $142,000
Q3 2020

Nov 06, 2020

SELL
$11.21 - $13.82 $303,275 - $373,886
-27,054 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$9.8 - $12.77 $265,129 - $345,479
27,054 New
27,054 $308,000
Q4 2019

Feb 12, 2020

SELL
$13.12 - $17.06 $131,331 - $170,770
-10,010 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$12.75 - $19.01 $127,627 - $190,290
10,010 New
10,010 $137,000
Q2 2018

Aug 07, 2018

SELL
$10.35 - $16.45 $139,373 - $221,515
-13,466 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$8.0 - $12.8 $107,728 - $172,364
13,466 New
13,466 $148,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $257M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.